FDA Inspection 1259244 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on Dec 13, 2024 in Lynchburg, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 13, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lynchburg, VA (United States)